Compare SMID & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMID | CBUS |
|---|---|---|
| Founded | 1960 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 69.9M |
| IPO Year | 1995 | 2017 |
| Metric | SMID | CBUS |
|---|---|---|
| Price | $35.20 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 8.6K | ★ 172.4K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.92 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $88,866,000.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | $15.86 | ★ N/A |
| Revenue Growth | ★ 16.37 | N/A |
| 52 Week Low | $25.13 | $1.09 |
| 52 Week High | $47.64 | $3.40 |
| Indicator | SMID | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 57.70 |
| Support Level | $34.53 | $1.60 |
| Resistance Level | $36.15 | $1.77 |
| Average True Range (ATR) | 1.50 | 0.14 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 64.26 | 63.64 |
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.